Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Meyronet

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Neuro-Oncology Advances|June 27, 2025
Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 casesAurelien Maureille, Enora Vauleon, David Meyronet, et al.
Cell Reports|May 12, 2021
VEGF counteracts amyloid-β-induced synaptic dysfunctionLaurent Martin, Pauline Bouvet, Naura Chounlamountri, et al.
Scientific Reports|November 9, 2022
Machine learning-based detection of label-free cancer stem-like cell fateAlexis J Chambost, Nabila Berabez, Olivier Cochet-Escartin, et al.
Neurosurgical Review|July 1, 2021
Characteristics and management of hydrocephalus in adult patients with cerebellar glioblastoma: lessons from a French nationwide series of 118 casesThiébaud Picart, Chloé Dumot, David Meyronet, et al.
Neuro-Oncology Advances|October 16, 2020
Alterations of cerebral microcirculation in peritumoral edema: feasibility of in vivo sidestream dark-field imaging in intracranial meningiomasMoncef Berhouma, Thiebaud Picart, Chloe Dumot, et al.
Oncotarget|December 6, 2015
Molecular heterogeneity of glioblastomas: does location matter?Emilie Denicolaï, Emeline Tabouret, Carole Colin, et al.
Cancers|October 26, 2024
Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 CasesGrigorios Gkasdaris, Julien Berthiller, Jacques Guyotat, et al.
Acta Neuropathologica Communications|December 20, 2025
Functional analysis of telomere maintenance mechanisms is more informative than immunohistochemistry for ATRX mutation interpretation in GliomasClemence Guerriau, Camille Léonce, Catherine Carpentier, et al.
Acta Neuropathologica Communications|April 3, 2016
Characteristics of gliomas in patients with somatic IDH mosaicismCharlotte Bonnet, Laure Thomas, Dimitri Psimaras, et al.
Cancers|July 20, 2021
The Immune Microenvironment of Chordomas: An Immunohistochemical AnalysisMaroa Dridi, Lila Krebs-Drouot, David Meyronet, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Neuro-Oncology Advances|June 27, 2025
Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 casesAurelien Maureille, Enora Vauleon, David Meyronet, et al.
Cell Reports|May 12, 2021
VEGF counteracts amyloid-β-induced synaptic dysfunctionLaurent Martin, Pauline Bouvet, Naura Chounlamountri, et al.
Scientific Reports|November 9, 2022
Machine learning-based detection of label-free cancer stem-like cell fateAlexis J Chambost, Nabila Berabez, Olivier Cochet-Escartin, et al.
Neurosurgical Review|July 1, 2021
Characteristics and management of hydrocephalus in adult patients with cerebellar glioblastoma: lessons from a French nationwide series of 118 casesThiébaud Picart, Chloé Dumot, David Meyronet, et al.
Neuro-Oncology Advances|October 16, 2020
Alterations of cerebral microcirculation in peritumoral edema: feasibility of in vivo sidestream dark-field imaging in intracranial meningiomasMoncef Berhouma, Thiebaud Picart, Chloe Dumot, et al.
Oncotarget|December 6, 2015
Molecular heterogeneity of glioblastomas: does location matter?Emilie Denicolaï, Emeline Tabouret, Carole Colin, et al.
Cancers|October 26, 2024
Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 CasesGrigorios Gkasdaris, Julien Berthiller, Jacques Guyotat, et al.
Acta Neuropathologica Communications|December 20, 2025
Functional analysis of telomere maintenance mechanisms is more informative than immunohistochemistry for ATRX mutation interpretation in GliomasClemence Guerriau, Camille Léonce, Catherine Carpentier, et al.
Acta Neuropathologica Communications|April 3, 2016
Characteristics of gliomas in patients with somatic IDH mosaicismCharlotte Bonnet, Laure Thomas, Dimitri Psimaras, et al.
Cancers|July 20, 2021
The Immune Microenvironment of Chordomas: An Immunohistochemical AnalysisMaroa Dridi, Lila Krebs-Drouot, David Meyronet, et al.
Pageof 14